Previous 10 | Next 10 |
GERMANTOWN, Md., March 29, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, announces that it has entered a collabora...
BioHiTech Global (BHTG) +44% on receiving $2M in Digester orders.Upstart Holdings (UPST) +39% on Q4 results.Neos Therapeutics (NEOS) +30%.Seneca Biopharma (SNCA) +26%.Evolving Systems (EVOL) +24% on Q4 results.Can-Fite BioPharma (CANF) +17% on announcing new data from a pr...
Orgenesis (ORGS) entered a collaboration with MIDA Biotech B.V. to establish point-of-care centers at hospitals and other medical institutions across western Europe.Orgenesis and MIDA plan to deploy Orgenesis Mobile Processing Units and Labs at leading hospitals for the onsite developme...
GERMANTOWN, Md., March 18, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, announces that it has entered a collabora...
Orgenesis ([[ORGS]] +2.7%) has entered the planned second phase of a collaboration with Hospital Infantil Universitario Niño Jesús in Madrid, Spain to further develop and commercialize the hospital’s proprietary Celyvir therapy for the treatment of solid tumors...
GERMANTOWN, Md., March 11, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, today announces that it has entered the p...
Orgenesis. (ORGS) Q4 2020 Earnings Conference Call March 09, 2021, 08:30 AM ET Company Participants David Waldman - Investor Relations Vered Caplan - Chief Executive Officer Neil Reithinger - Chief Financial Officer Conference Call Participants Bruce Jackson - The Benchmark Company Kelvin See...
Revenue increases 96% to $7.7 million for 2020 Projects to more than double in revenue for 2021 based on current contracts already in hand Orgenesis to host conference call today at 8:30AM ET GERMANTOWN, Md., March 09, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc ...
Orgenesis ([[ORGS]] +4.7%) signs a collaboration agreement with Cure Therapeutics and Dong-a University Hospital in South Korea that will see a development of immunotherapies targeting cancers and infectious diseases.The teams will align to utilize Orgenesis' Mobile Processing ...
GERMANTOWN, Md., March 08, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc . (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), Dong-a University Hospital in Sout...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.7% to $127.255 on volume of 88,797,787 shares Ascent Solar Technologies Inc (ASTI) rose 9.6% to $0.1183 on volume of 88,651,038 shares Crown Electrokinetics Corp. (CRKN) fell 19.0% to $0.040499 on volu...